Carly Pearce has made waves in country music with her singing and songwriting, and even earned a Grammy in 2023 for her song ...

The majority of patients who reported pericardial effusion following oral minoxidil use were men, which was a significantly higher rate than all other adverse events associated with oral minoxidil use ...

Phyllodes tumors are a rare type of breast growth. Less than 1% of all breast tumors are this type. Most are not cancer, called benign. But about 25% of these tumors are cancerous (or malignant).

Itchy skin, or pruritus, can be a symptom of some cancers, including blood-related, skin, liver, gallbladder, and bile-duct cancer cancers. However, other causes of itching are more common. Itching ...

What’s in a Pathology Report? Pathology reports can vary depending on what type of cancer you have. You may read about different tests and terms. But most reports usually have these sections.

Dietary supplements by themselves can’t fully treat cancer, but there are some supplements that can potentially help prevent cancer or assist in your cancer recovery. When it comes to dietary ...

A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. Fellow Japanese drugmaker Ono Pharmaceutical has won an FDA green light for vimseltinib to treat ...

H. Ma and S. Srivastava are joint first authors of this article. R. Sundar and P. Tan are joint corresponding and senior authors of this article.

Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at the time of the diagnosis and increase their risk of future heart disease, ...

The TAT index was a more reliable predictor of thromboembolic risk in patients with cervical cancer than other indicators, and a combined diagnostic approach that incorporated t-PAIC, TM, TAT, and PIC ...

In this week’s View, Dr. Eagle looks at cardiac rehabilitation for people with heart failure. He then discusses managing cardiovascular (CV) disease in cancer survivors who have completed cancer ...